
Synolo® Biometrics was created to commercialize the infant biometrics collection technology developed at UC San Diego with funding from the Gates Foundation. This technology was clinically proven in a large joint study performed in a major hospital in Mexico.
Since forming Synolo® in 2021, the original "Panda" prototype has been transformed into a fully commercialized unit with proprietary, real-time, high resolution image processing, ergonomic design, and a robust SDK for OEM integration that is already successfully deployed in the field in the US and Brazil.
2025
Synolo® Neo is the only biometrics device to offer both contact and non-contact capabilities in the same device. You can now rapidly switch between our patented non-contact and contact tops to capture infant, child and adult fingerprints with either technology in high resolution, age corrected images, providing a highly flexible solution for lifelong identification.

2025
Synolo® Neo becomes the first non-contact device designed for infant and child as well as adult biometrics to receive FBI PIV single finger certification.

2024

2023

2022

2022

2021
Synolo® Biometrics was formed by key members of the UCSD team and seasoned entrepreneurs to commercialize the technology. Funding was provided by BioPacific Investors angel group.

2019
The resulting pilot study led by UCSD's team validated that a new, non-contact, high resolution fingerprint device (the 'Panda') combined with novel image processing algorithms, could successfully identify 500 newborns and infants in a hospital setting.

2017
A $5M grant provided to UC San Diego started it all. The Gates Foundation approached Dr. Eliah Aronoff-Spencer to lead a project to determine if - and how - newborns and infants could be identified for vaccine delivery using biometrics.


Chairman & Co-founder

CEO & Co-founder

CTO & Co-founder

Co-founder & Neo Visionary

Business Development Manager
Get in touch and discover how Synolo® Neo can transform civil identification.
Contact Us